Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anal Canal Squamous Cell Carcinoma”

52 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 52 results

Not applicableStudy completedNCT02379039
What this trial is testing

Multimodal Monitoring of Radiotherapy Response in Squamous Cell Cancer

Who this might be right for
Squamous CarcinomaHead and Neck CancerAnal Cancer+3 more
Umeå University 118
Early research (Phase 1)Ended earlyNCT04989387
What this trial is testing

Study of INCA 0186 in Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsSquamous Cell Carcinoma of the Head and Neck (SCCHN)Gastrointestinal (GI) Malignancies
Incyte Corporation 57
Early research (Phase 1)Study completedNCT00397384
What this trial is testing

Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer

Who this might be right for
Adenocarcinoma of the ColonAdenocarcinoma of the RectumAdvanced Adult Primary Liver Cancer+64 more
National Cancer Institute (NCI) 43
Testing effectiveness (Phase 2)Study completedNCT02402842
What this trial is testing

Clinical and Biological Interest of Taxanes in Advanced Squamous Cell Anal Carcinoma

Who this might be right for
Anal Canal Carcinoma
Centre Hospitalier Universitaire de Besancon 70
Early research (Phase 1)Active Not RecruitingNCT05858736
What this trial is testing

Safety, PK and Efficacy of AI-061 in Advanced Solid Tumors

Who this might be right for
MelanomaNon Small Cell Lung CancerHead and Neck Squamous Cell Carcinoma+14 more
OncoC4, Inc. 18
Testing effectiveness (Phase 2)Active Not RecruitingNCT02437851
What this trial is testing

Surgery in Treating Patients With Early Stage Anal Canal or Perianal Cancer and HIV Infection

Who this might be right for
Anal Squamous Cell CarcinomaHIV InfectionStage 0 Anal Canal Cancer+1 more
AIDS Malignancy Consortium 16
Testing effectiveness (Phase 2)Study completedNCT05060471
What this trial is testing

PD-1 Blockade Combined With Chemotherapy Followed by Concurrent Immunoradiotherapy for Locally Advanced SCCA Patients

Who this might be right for
Anal Canal CancerAnal Squamous Cell CarcinomaAnal Cancer+3 more
Sun Yat-sen University 25
Early research (Phase 1)Looking for participantsNCT04429542
What this trial is testing

Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors

Who this might be right for
Head and Neck Squamous Cell CarcinomaSquamous Cell Carcinoma of Anal CanalColorectal Cancer+8 more
Bicara Therapeutics 292
Early research (Phase 1)Study completedNCT00004074
What this trial is testing

Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu

Who this might be right for
Advanced Adult Primary Liver CancerAnaplastic Thyroid CancerBone Metastases+124 more
National Cancer Institute (NCI) 15
Early research (Phase 1)Study completedNCT03517488
What this trial is testing

XmAb®20717 in Subjects With Selected Advanced Solid Tumors

Who this might be right for
MelanomaBreast CarcinomaHepatocellular Carcinoma+25 more
Xencor, Inc. 150
Testing effectiveness (Phase 2)Study completedNCT00093379
What this trial is testing

Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer

Who this might be right for
Anal Cancer
M.D. Anderson Cancer Center 20
Testing effectiveness (Phase 2)Ended earlyNCT01843452
What this trial is testing

Phase II Study of Concomitant Intensity-modulated Radiotherapy Combined to Capecitabine, Mitomycin and Panitumumab in Patients With Stage II-IIIB Squamous-cell Carcinoma of the Anal Canal

Who this might be right for
Carcinoma of Anal Canal
Centre Hospitalier Universitaire Vaudois 8
Large-scale testing (Phase 3)UnknownNCT05374252
What this trial is testing

Chemoradiotherapy Combined With or Without PD-1 Blockade in Anal Canal Squamous Carcinoma Patients

Who this might be right for
Anal Canal Cancer Stage IIIAnal Squamous Cell CarcinomaAnal Canal Cancer+1 more
Sixth Affiliated Hospital, Sun Yat-sen University 102
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)UnknownNCT03302858
What this trial is testing

A Safety and Efficacy Trial of Circumferential Anal Canal Radiofrequency Ablation for High-Grade Anal Intraepithelial Neoplasia Using the BARRX™ Anorectal Wand

Who this might be right for
HSIL, High Grade Squamous Intraepithelial LesionsAnal CancerHPV-Related Squamous Cell Carcinoma+3 more
Stephen E. Goldstone 70
Early research (Phase 1)Study completedNCT00031681
What this trial is testing

7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)

Who this might be right for
Advanced Adult Primary Liver CancerCarcinoma of the AppendixEstrogen Receptor-negative Breast Cancer+85 more
National Cancer Institute (NCI) 41
Testing effectiveness (Phase 2)Study completedNCT00423293
What this trial is testing

Intensity-Modulated Radiation Therapy, Fluorouracil, and Mitomycin C in Treating Patients With Invasive Anal Cancer

Who this might be right for
Anal Cancer
Radiation Therapy Oncology Group 63
Testing effectiveness (Phase 2)Active Not RecruitingNCT02834013
What this trial is testing

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

Who this might be right for
Acinar Cell CarcinomaAdenoid Cystic CarcinomaAdrenal Cortical Carcinoma+91 more
National Cancer Institute (NCI) 818
Early research (Phase 1)Study completedNCT04580485
What this trial is testing

INCB106385 Alone or in Combination With Immunotherapy in Advanced Solid Tumors

Who this might be right for
Ovarian CancerBladder CancerNon Small Cell Lung Cancer+8 more
Incyte Corporation 54
Testing effectiveness (Phase 2)Active Not RecruitingNCT02314169
What this trial is testing

Nivolumab With or Without Ipilimumab in Treating Patients With Refractory Metastatic Anal Canal Cancer

Who this might be right for
Anal Canal Squamous Cell CarcinomaMetastatic Anal Canal CarcinomaStage IV Anal Cancer AJCC v8
National Cancer Institute (NCI) 37
Load More Results